Results 121 to 130 of about 23,261 (287)

Efficacy of caspofungin dose escalation against Candida albicans and Candida glabrata clinical isolates [PDF]

open access: yes, 2016
Munkánk során meghatároztuk a caspofungin által kifejtett ölési rátát RPMI-1640-ben, valamint 50% humán szérummal kiegészített tápközegben C. albicans és C. glabrata klinikai izolátumok ellen.
Domán, Marianna
core  

The Surgical Infection Society revised guidelines on the management of intra-abdominal infection [PDF]

open access: yes, 2017
Background: Previous evidence-based guidelines on the management of intra-abdominal infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and 2010. At the time the most recent guideline was released, the plan was to update
Chang, Phillip K   +11 more
core   +3 more sources

Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata

open access: yesEmerging Microbes and Infections, 2019
Echinocandin resistance in Candida glabrata poses a serious clinical challenge. The underlying resistance mechanism of a pan-echinocandin-resistant C. glabrata isolate (strain L74) was investigated in this study.
X. Hou   +14 more
semanticscholar   +1 more source

Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre

open access: yesMycoses, Volume 68, Issue 12, December 2025.
ABSTRACT Background Recent literature indicates a decline in rates of candidemia in the general population. Objectives To analyse temporal trends in candidemia among patients with solid tumours and haematological malignancies admitted to a dedicated cancer centre.
Mohammad El‐Atoum   +4 more
wiley   +1 more source

Results of treatment for candidemia in patients with blood system tumors

open access: yesТерапевтический архив, 2013
AIM: To study the etiology, clinical manifestations, risk factors, and results of treatment for candidemia (CE) in patients with blood system tumors/MATERIAL AND METHODS: The investigation included the patients with CE and hemoblastoses treated at the ...
G A Kliasova   +5 more
doaj  

Hsp21potentiates antifungal drug tolerance in Candida albicans [PDF]

open access: yes, 2013
Peer reviewedPublisher ...
Alix Therese Coste   +52 more
core   +2 more sources

Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization

open access: yesFrontiers in Microbiology, 2019
The pathogenic yeast Candida glabrata has become a public health issue due to the increasing number of echinocandin resistant clinical strains reported.
O. Rivero-Menendez   +9 more
semanticscholar   +1 more source

Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata. [PDF]

open access: yes, 2017
The echinocandins are relatively new antifungal drugs that represent, together with the older azoles, the recommended and/or preferred agents to treat candidaemia and other forms of invasive candidiasis in human patients.
De Carolis, E.   +6 more
core   +2 more sources

Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus

open access: yesmBio, 2019
Resistance to first-line triazole antifungal agents among Aspergillus species has prompted the use of second-line therapy with echinocandins. As the number of Aspergillus-infected patients treated with echinocandins is rising, clinical observations of ...
Shruthi Satish   +10 more
semanticscholar   +1 more source

Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine. [PDF]

open access: yes, 2013
Journal ArticleResearch Support, Non-U.S. Gov'tCopyright © 2015 by the American Society for Microbiology.Post print version deposited in accordance with SHERPA RoMEO guidelines.Chloroquine (CQ) has been a mainstay of antimalarial drug treatment for ...
Avery, SV   +5 more
core   +5 more sources

Home - About - Disclaimer - Privacy